This tender with title 453468-Awarded - Czech Republic – Antineoplastic agents – Medicinal products containing dostarlimab, enfortumab vedotin, gemtuzumab ozogamicin, glofitamab, nivolumab and relatlimab, panitumumab, ramucirumab -- Contract Value: 129 097 979,50 CZK has been published on Bidding Source portal dated 14 Jul 2025 for the country of Czech Republic. It has been categorized on Antineoplastic agents. For similar tenders you can see tenders mentioned below of this page.
Contract Value: 129 097 979,50 CZK
General Information
Contract Value: 129 097 979,50 CZK
For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now
Or Request a call back now and one of our representatives will contact you. Contact us